Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Primary Treatment for Acute Graft-Versus-Host Disease (GVHD): A Single-Center Analysis of 458 Japanese Patients.

Takahiro Fukuda, Toshihiro Takahashi, Yukiko Iisaka, Fusako Ohara-Waki, Sung-Won Kim, Shin-ichiro Mori, Ryuji Tanosaki, Atsushi Makimoto, Kensei Tobinai, Yoichi Takaue

Blood (2007) 110 (11): 4976.

https://doi.org/10.1182/blood.V110.11.4976.4976

Published: 2007

Journal Articles

Impact of Hepatic Toxicities on Survival after Allogeneic Hematopoietic Cell Transplantation (HCT): Comparison of Reduced-Intensity Versus Conventional Conditioning Regimens at a Single Center.

Atsushi Fujieda, Takahiro Fukuda, Fusako Ohara, Satoshi Yamasaki, Sungwon Kim, Shin-ichiro Mori, Ryuji Tanosaki, Yuji Heike, Atsushi Makimoto, Kensei Tobinai, Yoichi Takaue

Blood (2006) 108 (11): 2976.

https://doi.org/10.1182/blood.V108.11.2976.2976

Published: 2006

Journal Articles

Comparison of Outcomes after Reduced-Intensity Versus Myeloablative Stem Cell Transplantation in 128 Patients with Acute Myeloid Leukemia: A Single-Center Analysis.

Fusako Ohara, Takahiro Fukuda, Ruri Kato, Satoshi Yamasaki, Sung-Won Kim, Shin-ichiro Mori, Ryuji Tanosaki, Yuji Heike, Atsushi Makimoto, Kensei Tobinai, Yoichi Takaue

Blood (2006) 108 (11): 3023.

https://doi.org/10.1182/blood.V108.11.3023.3023

Published: 2006

Journal Articles

Age-Related Risk of Non-Relapse Mortality Associated with Acute Graft-Versus-Host Disease.

Takahiro Fukuda, Yukiko Iisaka, Fusako Ohara, Atsushi Fujieda, Satoshi Yamasaki, Sung-Won Kim, Shin-ichiro Mori, Ryuji Tanosaki, Yuji Heike, Atsushi Makimoto, Kensei Tobinai, Yoichi Takaue

Blood (2006) 108 (11): 40.

https://doi.org/10.1182/blood.V108.11.40.40

Published: 2006

Journal Articles

Allogeneic Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies Not in Remission: The Anti-Tumor Effect of Reduced-Intensity Conditioning Is Comparable to That of Conventional Myeloablative Conditioning.

Dai Maruyama, MD, Takahiro Fukuda, MD, Ruri Kato, MD, Satoshi Yamasaki, MD, Eiji Usui, MD, Yuriko Morita, MD, Sung-Won Kim, MD, Shin-ichiro Mori, MD, Ryuji Tanosaki, MD, Kinuko Tajima, PhD, Yuji Heike, MD, Atsushi Makimoto, MD, Kensei Tobinai, MD, Yoichi Takaue, MD

Blood (2005) 106 (11): 1142.

https://doi.org/10.1182/blood.V106.11.1142.1142

Published: 2005

Journal Articles

Graft-Versus-Tumor Effects after Allogeneic Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies.

Eiji Usui, MD, Takahiro Fukuda, MD, Ruri Kato, MD, Satoshi Yamasaki, MD, Dai Maruyama, MD, Yuriko Morita, MD, Sung-Won Kim, MD, Shin-ichiro Mori, MD, Ryuji Tanosaki, MD, Kinuko Tajima, PhD, Yuji Heike, MD, Atsushi Makimoto, MD, Kensei Tobinai, MD, Yoichi Takaue, MD

Blood (2005) 106 (11): 2015.

https://doi.org/10.1182/blood.V106.11.2015.2015

Published: 2005

Journal Articles

Hematopoietic Cell Transplantation-Specific Comorbidity Index To Predict Non-Relapse Mortality and Survival after Allografting.

Ruri Kato, MD, Takahiro Fukuda, MD, Eiji Usui, MD, Satoshi Yamasaki, MD, Dai Maruyama, MD, Yuriko Morita, MD, Sung-Won Kim, MD, Shin-ichiro Mori, MD, Ryuji Tanosaki, MD, Kinuko Tajima, PhD, Yuji Heike, MD, Atsushi Makimoto, MD, Kensei Tobinai, MD, Yoichi Takaue, MD

Blood (2005) 106 (11): 2731.

https://doi.org/10.1182/blood.V106.11.2731.2731

Published: 2005

Journal Articles

Collection of Autologous Peripheral Blood Stem Cells (PBSC): Safety Evaluations during the Peri-Apheresis Period.

Ryuji Tanosaki, MD, Yukie Hotate, MT, Makiko Shimada, MT, Naoki Inoue, MT, Yasushi Onishi, MD, Sung-Won Kim, MD, Atsushi Makimoto, MD, Ako Hosono, MD, Masahiro Kami, MD, Shin-ichiro Mori, MD, Kensei Tobinai, MD, Yoichi Takaue, MD.

Blood (2004) 104 (11): 5038.

https://doi.org/10.1182/blood.V104.11.5038.5038

Published: 2004

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Primary Treatment for Acute Graft-Versus-Host Disease (GVHD): A Single-Center Analysis of 458 Japanese Patients.

Impact of Hepatic Toxicities on Survival after Allogeneic Hematopoietic Cell Transplantation (HCT): Comparison of Reduced-Intensity Versus Conventional Conditioning Regimens at a Single Center.

Comparison of Outcomes after Reduced-Intensity Versus Myeloablative Stem Cell Transplantation in 128 Patients with Acute Myeloid Leukemia: A Single-Center Analysis.

Age-Related Risk of Non-Relapse Mortality Associated with Acute Graft-Versus-Host Disease.

Allogeneic Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies Not in Remission: The Anti-Tumor Effect of Reduced-Intensity Conditioning Is Comparable to That of Conventional Myeloablative Conditioning.

Graft-Versus-Tumor Effects after Allogeneic Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies.

Hematopoietic Cell Transplantation-Specific Comorbidity Index To Predict Non-Relapse Mortality and Survival after Allografting.

Collection of Autologous Peripheral Blood Stem Cells (PBSC): Safety Evaluations during the Peri-Apheresis Period.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only